JP2024508088A5 - - Google Patents
Info
- Publication number
- JP2024508088A5 JP2024508088A5 JP2023541092A JP2023541092A JP2024508088A5 JP 2024508088 A5 JP2024508088 A5 JP 2024508088A5 JP 2023541092 A JP2023541092 A JP 2023541092A JP 2023541092 A JP2023541092 A JP 2023541092A JP 2024508088 A5 JP2024508088 A5 JP 2024508088A5
- Authority
- JP
- Japan
- Prior art keywords
- hsv
- oncolytic
- glycoprotein
- passage
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163200011P | 2021-02-09 | 2021-02-09 | |
| US63/200,011 | 2021-02-09 | ||
| US202163263528P | 2021-11-04 | 2021-11-04 | |
| US63/263,528 | 2021-11-04 | ||
| PCT/US2022/015703 WO2022173767A1 (en) | 2021-02-09 | 2022-02-08 | Oncolytic virus for systemic delivery and enhanced anti-tumor activities |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508088A JP2024508088A (ja) | 2024-02-22 |
| JP2024508088A5 true JP2024508088A5 (cg-RX-API-DMAC7.html) | 2025-02-18 |
Family
ID=80623426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541092A Pending JP2024508088A (ja) | 2021-02-09 | 2022-02-08 | 全身送達及び抗腫瘍活性の向上のための腫瘍溶解性ウイルス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240123004A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4291216A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024508088A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022219921A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3202849A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022173767A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230295661A1 (en) * | 2022-03-16 | 2023-09-21 | University Of Houston System | Persistent hsv gene delivery system |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8200523A (nl) | 1982-02-11 | 1983-09-01 | Univ Leiden | Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna. |
| US4879236A (en) | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| EP0273085A1 (en) | 1986-12-29 | 1988-07-06 | IntraCel Corporation | A method for internalizing nucleic acids into eukaryotic cells |
| US4952500A (en) | 1988-02-01 | 1990-08-28 | University Of Georgia Research Foundation, Inc. | Cloning systems for Rhodococcus and related bacteria |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5302523A (en) | 1989-06-21 | 1994-04-12 | Zeneca Limited | Transformation of plant cells |
| US5550318A (en) | 1990-04-17 | 1996-08-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| US5322783A (en) | 1989-10-17 | 1994-06-21 | Pioneer Hi-Bred International, Inc. | Soybean transformation by microparticle bombardment |
| US5484956A (en) | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
| US5384253A (en) | 1990-12-28 | 1995-01-24 | Dekalb Genetics Corporation | Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| US5610042A (en) | 1991-10-07 | 1997-03-11 | Ciba-Geigy Corporation | Methods for stable transformation of wheat |
| DK0604662T3 (da) | 1992-07-07 | 2008-10-20 | Japan Tobacco Inc | Fremgangsmåde til transformering af monocotyledon |
| US5702932A (en) | 1992-07-20 | 1997-12-30 | University Of Florida | Microinjection methods to transform arthropods with exogenous DNA |
| AU670316B2 (en) | 1992-07-27 | 1996-07-11 | Pioneer Hi-Bred International, Inc. | An improved method of (agrobacterium)-mediated transformation of cultured soybean cells |
| DE4228457A1 (de) | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen |
| GB9222888D0 (en) | 1992-10-30 | 1992-12-16 | British Tech Group | Tomography |
| US5656610A (en) | 1994-06-21 | 1997-08-12 | University Of Southern California | Producing a protein in a mammal by injection of a DNA-sequence into the tongue |
| FR2722208B1 (fr) | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
| US5871986A (en) | 1994-09-23 | 1999-02-16 | The General Hospital Corporation | Use of a baculovirus to express and exogenous gene in a mammalian cell |
| US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
| US5780448A (en) | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| US5945100A (en) | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
| US5981274A (en) | 1996-09-18 | 1999-11-09 | Tyrrell; D. Lorne J. | Recombinant hepatitis virus vectors |
| US6013265A (en) | 1996-10-22 | 2000-01-11 | University Of Maryland, Baltimore | Vaccine composition for herpes simplex virus and methods of using |
| US5994624A (en) | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
| US8986672B2 (en) * | 2005-06-23 | 2015-03-24 | The University Of Houston | Use of mutant Herpes Simplex Virus-2 for cancer therapy |
| US20150246086A1 (en) | 2005-06-23 | 2015-09-03 | The University Of Houston System | Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy |
| WO2012071276A1 (en) | 2010-11-23 | 2012-05-31 | Xiaoliu Zhang | Oncolytic virus as an inducer for innate antitumor immunity |
| EP3400291B2 (en) * | 2016-01-08 | 2024-02-28 | Replimune Limited | Engineered virus |
| ES2976558T3 (es) * | 2017-06-21 | 2024-08-05 | The Board Of Trustees Of The Leland Stanfordjunior Univ | Parámetros de dosificación para terapias de direccionamiento de CD47 en neoplasias hematológicas |
| CN112368007A (zh) * | 2018-05-31 | 2021-02-12 | 高等教育联邦系统-匹兹堡大学 | 抗原隐匿的溶瘤病毒 |
-
2022
- 2022-02-08 WO PCT/US2022/015703 patent/WO2022173767A1/en not_active Ceased
- 2022-02-08 JP JP2023541092A patent/JP2024508088A/ja active Pending
- 2022-02-08 EP EP22707286.5A patent/EP4291216A1/en active Pending
- 2022-02-08 CA CA3202849A patent/CA3202849A1/en active Pending
- 2022-02-08 US US18/264,737 patent/US20240123004A1/en active Pending
- 2022-02-08 AU AU2022219921A patent/AU2022219921A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mal et al. | Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells | |
| Cui et al. | Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350 | |
| Diefenbach et al. | Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain | |
| Johnson et al. | Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus | |
| Rowe et al. | Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes | |
| Rux et al. | Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b | |
| CA2475604C (en) | An herpes simplex virus complex | |
| Hung et al. | The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway | |
| WO2022089471A1 (zh) | 一种β冠状病毒多聚体抗原、其制备方法和应用 | |
| Modrow et al. | Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines. | |
| JP2001509373A5 (cg-RX-API-DMAC7.html) | ||
| CA2177699A1 (en) | Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition | |
| US20140227281A1 (en) | Methods of Treating Herpesvirus Infections | |
| WO2019044926A1 (ja) | 抗HSV gBモノクローナル抗体又はその抗原結合断片 | |
| KITAY et al. | Protein–protein interactions between Epstein–Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins | |
| Pratt et al. | Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4 | |
| WO2019018796A1 (en) | VACCINE EPITOPES AGAINST HERPES SIMPLEX VIRUS RECOGNIZED SPECIFICALLY BY MEMORY T LYMPHOCYTES RESIDING IN FABRICS | |
| Haarr et al. | Utilization of internal AUG codons for initiation of protein synthesis directed by mRNAs from normal and mutant genes encoding herpes simplex virus-specified thymidine kinase | |
| US12258408B2 (en) | Oncolytic virus expressing PD-1 binding protein and application of oncolytic virus | |
| JP2021526387A (ja) | 抗原的にステルス化された腫瘍溶解性ウイルス | |
| Chung et al. | Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) | |
| US5843405A (en) | Epstein-Barr virus peptides and antibodies against these peptides | |
| Wang et al. | Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons | |
| CN121443325A (zh) | 激动剂胞外囊泡 | |
| Derbigny et al. | The EICP22 protein of equine herpesvirus 1 physically interacts with the immediate-early protein and with itself to form dimers and higher-order complexes |